Peer-Reviewed Publications

      The development of heat substation for drying waste heat utilisation

      Gariev, A. O.; Klemeš, J. J.; Kusakov, S. K.; Tovazhnyansky, L. L.; Anokhin, P.; Kapustenko, P. O.; Arsenyeva, O. P.; Čuček, L.
      Published
      Aug 20, 2014
      DOI
      10.3303/cet1439235
      Link to publication
      Topic
      Summary

      The problem solution of waste heat utilization at the tobacco factory is considered in this work. The analysis of the possibility of waste heat utilization and appropriate calculations of plate heat exchangers were carried out. The method for multi component mixture condensation calculation is used. This allows obtaining optimal parameters for the working conditions of the heat exchangers according to the energy efficiency retrofit of industrial enterprises. The design of heat substation for waste heat utilisation was developed.

      Related Publications

      Use of capillary aerosol generator in continuous production of controlled aerosol for non-clinical studies

      Aerosol Physics Pre-clinical Toxicology

      Key Challenges and Recommendations for In Vitro Testing of Tobacco Products for Regulatory Applications: Consideration of Test Materials and Exposure Parameters

      Pre-clinical Toxicology

      Quantification and mapping of alkylation in the human genome reveal single nucleotide resolution precursors of mutational signatures

      Pre-clinical Toxicology

      Meta-analysis of the effects of smoking and smoking cessation on triglyceride levels

      Clinical

      An in vitro evaluation of e-vapor products: The contributions of chemical adulteration, concentration, and device power

      Pre-clinical Toxicology

      Tobacco heating system has less impact on bone metabolism than cigarette smoke

      Pre-clinical Toxicology

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.